Captor Therapeutics Spolka Akcyjna reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was PLN 43.32 million compared to PLN 20.84 million a year ago. Basic loss per share from continuing operations was PLN 10.29 compared to PLN 5.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.4 PLN | -2.05% | -7.95% | -22.83% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.83% | 88.89M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CTX Stock
- News Captor Therapeutics Spolka Akcyjna
- Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2023